EDITOR'S PICK: New potential drug combination for most common form of non-Hodgkin lymphoma Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin lymphoma. Although 60% of patients can be cured with a currently available combination therapy, this leaves a substantial number...